CID 16134240

5'-d[tg]-spa-d[aag]-spa-d[tcacc]-spa-d[gcc]-spa-dt-3', phosphorothioate oligodeoxynucleotide

Structural Information

Molecular Formula
C235H281N75O87P18S18
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3C(N(CC(C3OC)N4C=NC5=C(N=CN=C54)N)C(C6=CC=CC=C6)C7=CC=CC=C7)COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C(N(CC(C1OC)N1C=NC2=C(N=CN=C21)N)C(C1=CC=CC=C1)C1=CC=CC=C1)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=O)(OC1C(N(CC(C1OC)N1C=NC2=C(N=CN=C21)N)C(C1=CC=CC=C1)C1=CC=CC=C1)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C(N(CC(C1OC)N1C=NC2=C(N=CN=C21)N)C(C1=CC=CC=C1)C1=CC=CC=C1)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)O)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)S)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)O
InChI
InChI=1S/C235H281N75O87P18S18/c1-114-72-298(233(323)286-219(114)312)166-58-133(311)147(367-166)83-354-412(341,430)394-198-129(294(190(117-32-16-8-17-33-117)118-34-18-9-19-35-118)75-125(194(198)345-4)301-104-265-180-202(241)251-97-258-209(180)301)79-350-399(328,417)381-134-59-167(289-53-48-161(236)275-228(289)318)368-149(134)85-356-404(333,422)386-137-62-170(292-56-51-164(239)278-231(292)321)372-153(137)89-359-409(338,427)393-146-71-179(310-113-274-189-218(310)282-227(250)285-224(189)317)380-160(146)96-366-415(344,433)397-200-130(295(191(119-36-20-10-21-37-119)120-38-22-11-23-39-120)76-127(196(200)347-6)303-106-267-182-204(243)253-99-260-211(182)303)80-351-400(329,418)382-135-60-168(290-54-49-162(237)276-229(290)319)369-150(135)86-355-403(332,421)385-136-61-169(291-55-50-163(238)277-230(291)320)371-152(136)88-358-408(337,426)390-141-66-174(305-108-269-184-206(245)255-101-262-213(184)305)375-155(141)90-360-405(334,423)387-138-63-171(293-57-52-165(240)279-232(293)322)370-151(138)87-357-407(336,425)389-140-65-173(300-74-116(3)221(314)288-235(300)325)374-154(140)94-364-413(342,431)395-199-131(296(192(121-40-24-12-25-41-121)122-42-26-13-27-43-122)77-126(195(199)346-5)302-105-266-181-203(242)252-98-259-210(181)302)81-352-402(331,420)384-145-70-178(309-112-273-188-217(309)281-226(249)284-223(188)316)379-158(145)93-363-411(340,429)391-142-67-175(306-109-270-185-207(246)256-102-263-214(185)306)376-156(142)91-361-410(339,428)392-143-68-176(307-110-271-186-208(247)257-103-264-215(186)307)377-159(143)95-365-414(343,432)396-201-132(297(193(123-44-28-14-29-45-123)124-46-30-15-31-47-124)78-128(197(201)348-7)304-107-268-183-205(244)254-100-261-212(183)304)82-353-401(330,419)383-144-69-177(308-111-272-187-216(308)280-225(248)283-222(187)315)378-157(144)92-362-406(335,424)388-139-64-172(373-148(139)84-349-398(326,327)416)299-73-115(2)220(313)287-234(299)324/h8-57,72-74,97-113,125-160,166-179,190-201,311H,58-71,75-96H2,1-7H3,(H,328,417)(H,329,418)(H,330,419)(H,331,420)(H,332,421)(H,333,422)(H,334,423)(H,335,424)(H,336,425)(H,337,426)(H,338,427)(H,339,428)(H,340,429)(H,341,430)(H,342,431)(H,343,432)(H,344,433)(H2,236,275,318)(H2,237,276,319)(H2,238,277,320)(H2,239,278,321)(H2,240,279,322)(H2,241,251,258)(H2,242,252,259)(H2,243,253,260)(H2,244,254,261)(H2,245,255,262)(H2,246,256,263)(H2,247,257,264)(H,286,312,323)(H,287,313,324)(H,288,314,325)(H2,326,327,416)(H3,248,280,283,315)(H3,249,281,284,316)(H3,250,282,285,317)
InChIKey
XSRHDFZTXYAXPO-UHFFFAOYSA-N
Compound name
1-[5-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[2-[[[2-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-(dihydroxyphosphinothioyloxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)-1-benzhydryl-4-methoxypiperidin-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)-1-benzhydryl-4-methoxypiperidin-3-yl]oxy-sulfanylphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)-1-benzhydryl-4-methoxypiperidin-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)-1-benzhydryl-4-methoxypiperidin-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

6678.0117 Da
Monoisotopic Mass

6.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 6679.0190 311.5
[M+Na]+ 6701.0009 311.5
[M-H]- 6677.0044 311.5
[M+NH4]+ 6696.0455 311.5
[M+K]+ 6716.9749 311.5
[M+H-H2O]+ 6661.0090 311.5
[M+HCOO]- 6723.0099 311.5
[M+CH3COO]- 6737.0256 311.5
[M+Na-2H]- 6698.9864 311.5
[M]+ 6678.0112 311.5
[M]- 6678.0122 311.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.